Response to: ‘Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series’ by Narváez
Khanna, Dinesh, Jahreis, Angelika, Lin, Celia J FLanguage:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2018-214477
Date:
October, 2018
File:
PDF, 136 KB
english, 2018